Access to anti-retroviral drugs, male in Malta

Malta: Access to anti-retroviral drugs, male was 74.0% in 2024. ▲ Rising

Latest (2024)
74.0%
Change on year
up 10.4%
World rank
58th
of 141 countries
All-time high
74.0%
in 2024
All-time low
17.0%
in 2004
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Malta, 2000–2024

204060802000201220242000: 23 %2001: 21 %2002: 20 %2003: 19 %2004: 17 %2005: 20 %2006: 20 %2007: 22 %2008: 25 %2009: 29 %2010: 33 %2011: 34 %2012: 39 %2013: 41 %2014: 43 %2015: 47 %2016: 47 %2017: 49 %2018: 57 %2019: 60 %2020: 63 %2021: 62 %2022: 61 %2023: 67 %2024: 74 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Malta is 74.0%, measured in 2024. That is the highest value across all 25 years on record.

The figure is up 10.4% on the previous year and up 72.1% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Malta peaked at 74.0% in 2024 and was at its lowest, 17.0%, in 2004.

That places Malta 58th out of 141 countries with data for 2024, putting it in the middle of the range.

The long-run direction has been consistently rising across the 25 years of available data.

Access to anti-retroviral drugs, male in Malta, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Malta, 2000 to 2024.
Year % Change
2000 23.0%
2001 21.0% -8.7%
2002 20.0% -4.8%
2003 19.0% -5.0%
2004 17.0% -10.5%
2005 20.0% +17.6%
2006 20.0% +0.0%
2007 22.0% +10.0%
2008 25.0% +13.6%
2009 29.0% +16.0%
2010 33.0% +13.8%
2011 34.0% +3.0%
2012 39.0% +14.7%
2013 41.0% +5.1%
2014 43.0% +4.9%
2015 47.0% +9.3%
2016 47.0% +0.0%
2017 49.0% +4.3%
2018 57.0% +16.3%
2019 60.0% +5.3%
2020 63.0% +5.0%
2021 62.0% -1.6%
2022 61.0% -1.6%
2023 67.0% +9.8%
2024 74.0% +10.4%

Averages by decade

DecadeAverage LowestHighest Years
2000s 21.6% 17.0% 29.0% 10
2010s 45.0% 33.0% 60.0% 10
2020s 65.4% 61.0% 74.0% 5

Countries ranked near Malta

  1. 55 Congo, Democratic Republic of the 75.0% compare
  2. 55 South Africa 75.0% compare
  3. 55 Viet Nam 75.0% compare
  4. 58 Argentina 74.0% compare
  5. 58 Bahamas 74.0% compare
  6. 58 Gabon 74.0% compare

See the full ranking of 160 places →

More gender data for Malta

All data for Malta →

Frequently asked questions

What is access to anti-retroviral drugs, male in Malta?
Access to anti-retroviral drugs, male in Malta was 74.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Malta?
The highest recorded value was 74.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Malta?
The lowest recorded value was 17.0% in 2004.
How does Malta rank for access to anti-retroviral drugs, male?
Malta ranks 58th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Malta?
Over the last ten years it is up 72.1%. The long-run trend across the full record is rising.
Where does this Malta data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Malta. Statizoid, drawing on UNAIDS estimates. Retrieved 08 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/malta/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/malta/">Access to anti-retroviral drugs, male in Malta</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.